A carregar...
Gefitinib is more effective in never-smokers with non-small-cell lung cancer: experience among Asian patients
We retrospectively analysed the results of patients with advanced non-small-cell lung cancer treated with gefitinib to derive clinical factors predictive of response and a favourable survival outcome. Patients were treated with gefitinib 250 mg per day and re-evaluated 4–8 weeks later with repeat CT...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2005
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361491/ https://ncbi.nlm.nih.gov/pubmed/15942627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602652 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|